Skip to content

Clinical trials

Phase 3 Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 3 Country / region: Canada Clear all

150 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20032
20046
20057
20065
20079
20089
20096
201011
20114
20127
20136
20146
20158
20164
20174
201810
20198
20208
20213
20226
20235
20243
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed83
Terminated24
Active, not recruiting23
Recruiting9
Unknown status6
Withdrawn2
Not yet recruiting1
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie12
Novartis Pharmaceuticals12
Amgen8
AstraZeneca7
Bayer5
Sanofi5
GlaxoSmithKline4
Ontario Clinical Oncology Group (OCOG)4
University Health Network, Toronto4
Astellas Pharma Global Development, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms150
Neoplasm Metastasis15
Neoplasms by Site15
Breast Neoplasms12
Carcinoma9
Carcinoma, Non-Small-Cell Lung9
Carcinoma, Hepatocellular8
Prostatic Neoplasms8
Recurrence8
Adenocarcinoma7

Trials

Showing 1 to 25 of 150. Each trial links to its page on Pharma Observatory.

50 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.